# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Christopher Reeve (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML024-SYN
- Date: 2026-10-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Teresa Galloway, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Six-month review: respiratory care, skin, bladder and kidney surveillance, vaccines, and plans for the winter. **S**

## History of present illness

Mr. Reeve returns six months after his first visit. He uses the pacer for three hours twice a day and the ventilator otherwise, with no respiratory infection since intake. His skin has stayed intact. He has had no symptoms of autonomic dysreflexia. His bladder and bowel programs are working, and he has had no unplanned hospital stay. His stool immunochemical test, HIV and hepatitis C screening from the preventive visit were negative. He feels well and wants to be protected for the winter, when he plans to keep traveling. **S**

| Element | Detail |
|---|---|
| Breathing | Pacer three hours twice a day; no infections |
| Skin | Intact |
| Screening results | Stool test, HIV and hepatitis C negative |
| Mood | Good; PHQ-9 2 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or weight change |
| Respiratory | Negative | Secretions thin and clear |
| Cardiovascular | Negative | No pounding headaches or flushing; no leg swelling |
| Genitourinary | Negative | Catheter draining well |
| Integumentary | Negative | No lasting redness |
| Psychiatric | Negative | Mood good |

6 systems reviewed. **S**

## Current medications

- Sennosides 8.6 mg oral tablet, two tablets at bedtime **S**
- Nitroglycerin 2% ointment, one inch to the skin of the chest only if systolic blood pressure stays at 150 mmHg or higher after the first steps of the autonomic dysreflexia plan; wipe off when pressure falls **S**
- Acetaminophen 500 mg oral tablet, two tablets up to three times a day as needed for neck and shoulder aching **S**
- Cholecalciferol (vitamin D3) 2000 units (50 mcg) oral capsule, one capsule daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 104/64 mmHg; pulse 60 bpm; respirations 12/min; temperature 36.3 °C; oxygen saturation 98% on his home ventilator settings via tracheostomy, no supplemental oxygen; weight 83 kg; BMI 22.3 kg/m². All vital signs are synthetic.

White cells: 6.8 10*3/uL; Hemoglobin: 13.4 g/dL; Sodium: 138 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.49 mg/dL (low); Cystatin C: 0.91 mg/L; eGFR (cystatin C): 92 mL/min/1.73 m²; Albumin: 4 g/dL; Braden scale: 12; Pain score (0 to 10): 2; PHQ-9: 2. All results are synthetic.

## Change since baseline

- White cells: 7.2 10*3/uL at baseline, 6.8 10*3/uL at this visit **S**
- Hemoglobin: 13.1 g/dL (low) at baseline, 13.4 g/dL at this visit **S**
- Sodium: 138 mmol/L at baseline, 138 mmol/L at this visit **S**
- Potassium: 4.2 mmol/L at baseline, 4.1 mmol/L at this visit **S**
- Creatinine: 0.48 mg/dL (low) at baseline, 0.49 mg/dL (low) at this visit **S**
- Cystatin C: 0.92 mg/L at baseline, 0.91 mg/L at this visit **S**
- eGFR (cystatin C): 90 mL/min/1.73 m² at baseline, 92 mL/min/1.73 m² at this visit **S**
- Albumin: 3.8 g/dL at baseline, 4 g/dL at this visit **S**
- Braden scale: 11 at baseline, 12 at this visit **S**
- Pain score (0 to 10): 3 at baseline, 2 at this visit **S**
- PHQ-9: 3 at baseline, 2 at this visit **S**

## Immunizations given today

- Influenza vaccine, inactivated, this season **S**
- COVID-19 vaccine, mRNA, this season **S**
- Hepatitis B vaccine (HepB-CpG), dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 83.0 kg by chair scale; blood pressure 104/64, pulse 60 |
| Respiratory | On the ventilator during the visit; clear; stoma and pacer lead sites clean |
| Skin | Intact at all pressure points; Braden score 12 |
| Extremities | No leg swelling; modified Ashworth 1 in the legs |
| Psychiatric | Engaged and good-humored |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Ventilator dependence with diaphragm pacing** (Z99.11). Pacer three hours twice a day for two months with stable saturation; no infection. Influenza, COVID-19 and hepatitis B vaccines given today; PCV20, RSV and the first zoster dose given last month. **S**
   - Winter plan: at the first sign of a chest infection, more cough-assist sessions and suctioning, temperature twice a day, and a same-day call to the clinic.
   - Further pacer step-up to be reviewed with Dr. Kovac after the winter.
2. **Chronic incomplete C2 tetraplegia** (G82.52). Six months without a pressure injury, autonomic dysreflexia, or hospital stay. Hemoglobin 13.4 g/dL and albumin 4.0 g/dL normal. Pain score 2; PHQ-9 2. **S**
   - Continue the current plans.
   - Second zoster dose by early in the new year.
   - Lipids, A1c and vitamin D at the one-year review.
3. **Neurogenic bladder with an indwelling catheter** (N31.9). Cystatin C 0.91 mg/L, eGFR 92: stable. **S**
   - Kidney and bladder ultrasound in six months.
4. **Neurogenic bowel** (K59.2). Program effective; stool immunochemical test negative. **S**
   - Repeat the stool test yearly.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Autonomic dysreflexia: episodes, baseline blood pressure, written plan, and nurse training | Every visit | Completed today | No episodes in six months; plan reviewed with two new relief nurses |
| Survey | Skin check and Braden scale | Every visit | Completed today | Intact; Braden 12 |
| Self-management | Seating, cushion, and pressure mapping | At least yearly and after any change in equipment, weight or skin | Up to date | Mapped and adjusted two months ago |
| Self-management | Catheter care and urinary symptoms | Every visit | Completed today | No symptoms; changes on schedule |
| Laboratory | Kidney function (cystatin C; creatinine unreliable with low muscle mass) | At baseline, then every 6 to 12 months | Completed today | Cystatin C 0.91 mg/L, eGFR 92; sodium 138, potassium 4.1 mmol/L; creatinine 0.49 mg/dL |
| Imaging | Kidney and bladder ultrasound | Yearly | Up to date | Normal upper tracts six months ago; next in six months |
| Laboratory | Blood count and albumin | Every 6 to 12 months | Completed today | White cells 6.8, hemoglobin 13.4 g/dL; albumin 4.0 g/dL |
| Self-management | Bowel program | Every visit | Completed today | Effective |
| Examination | Pacer conditioning, oxygen saturation, and secretion clearance | Every visit | Completed today | Pacer three hours twice a day; no infections; winter plan written |
| Self-management | Backup ventilator, suction, cough-assist device, and power plan | Every visit, with monthly checks by his nurses | Completed today | Checks up to date; winter power plan confirmed |
| Imaging | Bone density (DXA of the hip and knee regions) | Baseline, then every 2 years | Up to date | Next in about eighteen months |
| Laboratory | Lipids, A1c, and blood pressure | Yearly | Due | Due at the one-year review |
| Survey | Depression screen (PHQ-9) | At intake, then every 6 to 12 months and with any change | Completed today | PHQ-9 2 |
| Survey | Pain score and pain plan | Every visit | Completed today | Pain score 2 |
| Examination | Spasticity and range of motion | Every visit | Completed today | Modified Ashworth 1; daily ranging |
| Examination | Venous thromboembolism: leg swelling | Every visit; prophylaxis only during acute illness, surgery or immobilization | Completed today | No leg swelling |
| Self-management | Influenza, COVID-19 and hepatitis B vaccines | Influenza and COVID-19 each season; hepatitis B two doses a month apart | Completed today | All given today; hepatitis B dose 2 in one month |
| Referral | Spinal cord injury medicine review | At least yearly | Up to date | Next review with Dr. Kovac after the winter |

## Goal progress

- Lengthen time on the diaphragm pacer to at least three hours twice a day by six months, with stable oxygen saturation. Outcome by 2026-10-26: Pacer three hours twice a day; saturation 97 to 98% on the pacer. **S**
- No pressure injury: skin intact at every check through six months. Outcome by 2026-10-26: Skin intact at every visit; Braden 11 to 12. **S**
- Written autonomic dysreflexia plan held by him and every nurse, with all nurses trained, by the two-week visit. Outcome by 2026-04-27: Plan and wallet card in place; all regular nurses trained. **S**
- 25-hydroxyvitamin D at least 30 ng/mL within three months. Outcome by 2026-06-22: 34 ng/mL at ten weeks. **S**
- No unplanned hospital admission through six months. Outcome by 2026-10-26: No admission. **S**

## Guideline basis

- Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and Lows (Consortium for Spinal Cord Medicine) (2021), Paralyzed Veterans of America (Journal of Spinal Cord Medicine)
- Pressure Ulcer Prevention and Treatment Following Spinal Cord Injury: A Clinical Practice Guideline for Health-Care Providers, Second Edition (Consortium for Spinal Cord Medicine) (2014), Paralyzed Veterans of America
- Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers (Consortium for Spinal Cord Medicine) (2006), Paralyzed Veterans of America (Journal of Spinal Cord Medicine)
- The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up (2021), American Urological Association and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (Journal of Urology)
- Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2021), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Respiratory management following spinal cord injury: a clinical practice guideline for health-care professionals (Consortium for Spinal Cord Medicine) (2005), Paralyzed Veterans of America (Journal of Spinal Cord Medicine)
- Bone Health and Osteoporosis Management in Individuals with Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2022), Paralyzed Veterans of America
- Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2018), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Management of Mental Health Disorders, Substance Use Disorders, and Suicide in Adults with Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers (Consortium for Spinal Cord Medicine) (2021), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Prevention of Venous Thromboembolism in Individuals with Spinal Cord Injury: Clinical Practice Guidelines for Health Care Providers, 3rd ed. (Consortium for Spinal Cord Medicine) (2016), Paralyzed Veterans of America (Topics in Spinal Cord Injury Rehabilitation)
- Evaluation and Management of Pain After Spinal Cord Injury (Consortium for Spinal Cord Medicine) (2026), Paralyzed Veterans of America
- CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026), Aether Forge
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Hepatitis B dose 2 in one month and the second zoster dose by early in the new year. Review in three months, or the same day for fever, a chest infection, skin redness that does not fade, or autonomic dysreflexia that does not settle with the plan. **S**

